Greenberg Traurig Boosts London Corporate Bench with Baker McKenzie Partner

Why It Matters

The hire strengthens GT’s capability in complex, multinational transactions, sharpening its competitive edge in London’s corporate market. It underscores the firm’s broader strategy of expanding through senior‑partner equity hires despite a stable partner headcount.

Key Takeaways

• Robert Gray joins GT as shareholder, boosting London M&A bench.
• Gray handled €12bn ($13bn) Danish biotech merger in 2024.
• GT added 19 shareholders in two years, now 180 lawyers.
• Revenue rose 11.8% to $2.9bn, profit per partner $2.9m.
• Focus on industrials, agribusiness, CEE and Nordics sectors.

Pulse Analysis

Greenberg Traurig’s latest addition, Robert Gray, reinforces the firm’s London corporate bench with deep cross‑border M&A expertise. After nearly two decades at Baker McKenzie, Gray has advised on high‑profile transactions such as the €12 billion (≈$13 billion) merger of Danish biotech leaders Chr. Hansen and Novozymes, a complex lactase carve‑out to Kerry Group, and the GSK‑Pfizer consumer‑health joint venture.

His sector focus on industrials, agribusiness, and deals spanning Central‑Eastern Europe and the Nordics aligns with GT’s push to serve multinational investors throughout the deal lifecycle. The hire is part of a broader acceleration in GT’s London expansion, where the firm has added 19 shareholders in the past two years and now fields close to 180 lawyers. ‑based firms bolstering their European footprints to capture private‑equity, infrastructure and corporate work traditionally dominated by the Magic Circle. 9 million profit per equity partner in 2025.

For corporate clients, Gray’s arrival translates into immediate access to a lawyer who can navigate multiple jurisdictions and sector nuances, a valuable asset as deal structures become increasingly global. The move also pressures rival firms to deepen their own cross‑border capabilities, potentially tightening fee negotiations in the competitive London market. As GT continues to layer expertise in industrials, agribusiness and CEE/Nordic transactions, the firm is positioned to capture a larger share of high‑value M&A mandates and to sustain its revenue momentum into the next fiscal year.